Wei et al.21 demonstrated in vivo that a lower dose of EGCG (12.5 mg/kg) than the one used in our study (25 mg/kg) did not increase mature cells despite effectively reducing PML/RARα protein expression in the bone marrow of animals in pre-leukaemia phase. The gene discussed is PML; the disease is leukemia.